Top Markets
Coin of the day
Hepion Pharmaceuticals, Inc. Hepion Pharmaceuticals, Inc.

Hepion Pharmaceuticals, Inc.

HEPA
Rang în acțiuni #38693
Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is... Hepion Pharmaceuticals, Inc., a U.S.-based biopharmaceutical entity, is dedicated to developing therapeutic interventions for chronic hepatic ailments. Central to their efforts is Rencofilstat, a cyclophilin inhibitor that has successfully concluded Phase 2a clinical trials. This compound operates by disrupting multiple pathological pathways implicated in the worsening of liver disease. It is currently progressing through clinical development for non-alcoholic steatohepatitis (NASH) and is additionally being explored in nonclinical research for its potential to reduce liver fibrosis and lessen hepatocellular carcinoma tumor loads in experimental models of NASH. Moreover, Rencofilstat has exhibited antiviral properties against hepatitis B, C, and D viruses through diverse mechanisms. The company, established in 2013 and situated in Edison, New Jersey, rebranded as Hepion Pharmaceuticals, Inc. in July 2019, having previously operated as ContraVir Pharmaceuticals, Inc.
Preț acțiune
$0.073
Capitalizare de piață
$849.99K
Schimbare (1 zi)
4.29%
Schimbare (1 an)
21.67%
Țară
US
Tranzacționează Hepion Pharmaceuticals, Inc. (HEPA)

Categorie

Istoric al prețului acțiunii pentru Hepion Pharmaceuticals, Inc. (HEPA)
Cel mai mare preț de închidere: $0.06 pe 2026-08-01

Cel mai mic preț de închidere: $815.99K pe 2014-02-01
Istoric al prețului acțiunii pentru Hepion Pharmaceuticals, Inc. din 2014 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) -13.45%
2025 -99.75%
2024 -83.90%
2023 -47.81%
2022 -72.98%
2021 -35.82%
2020 -64.66%
2019 -80.01%
2018 -87.43%
2017 -77.91%
2016 -3.97%
2015 1.80%
2014 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$504.83 29.34%
US
$839.07 28.61%
NL
$728.83 6.71%
CH
$1.07K -6.40%
KR
$252.06 11.35%
BE